Company Overview and News
Equity benchmarks ended a volatile trading day on a negative note as consumer names as well as banks weighed. The Nifty ended below 11,250-mark, while the Sensex shed a little over 160 points. Rupee heading towards its low points also dented sentiment on the market.
524715 500325 INDUSINDBK RELIANCE 532978 BHRQY 533278 532454 BAJAJFINSV 532187 RIGD SUNPHARMA BHARTIARTL CLNDY COALINDIA RLNIY
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
It is yet another afternoon session for the bears as the Indian stock market continues to trade lower this Tuesday afternoon extending the morning loses with the Nifty50 down 101 points and is trading at 11,336 while the Sensex is trading lower by 316 points at 37,605.
PAGEIND 500325 JIPKY DABUR BRTQY BALMLAWRIE 511389 ASIANPAINT 532832 DBRQY 533137 DEN USHAMART 500096 532480 500696 EROSMEDIA BJJQY BRITANNIA BEL SUNTV RLNIY SBAZ PGDQY BHQRY AXB 523319 UHBTY 532827 ALBK CLGQY YYBKY 533122 ALBERTDA AXBA BAJAJFINSV BAJFINANCE TATASTEEL TATLY 500180 IBREALEST ANDHRABANK 500825 517146 500820 RELIANCE RTNPOWER 532418 HINDUNILVR 532978 530239 VIDEOIND 532733 532215 SUVEN 500470 AXISBANK CL RIGD HDFCBANK SNOWMAN 503100 500034 YESBANK PHOENIXLTD 533261 532648 JPASSOCIAT 538635 AXBKY 532532 TTST 524075 HDB 500049 SNQVY
The Indian stock market continues to remain weak this Tuesday afternoon with the Nifty50 down 30 points and is trading at 11,407 while the Sensex is trading lower by 102 points at 37,819.
500325 JIPKY DABUR BRTQY BALMLAWRIE 511389 DBRQY 532633 533137 DEN USHAMART 500096 532480 500696 EROSMEDIA BJJQY BRITANNIA BEL SUNTV RLNIY SBAZ BHQRY AXB 523319 UHBTY ALBK CLGQY YYBKY ALBERTDA AXBA BAJAJFINSV BAJFINANCE 533638 TATASTEEL TATLY 500180 ANDHRABANK 500825 517146 533271 RELIANCE 532418 HINDUNILVR ASHOKA 532978 530239 VIDEOIND 532733 532215 SUVEN 500470 532461 AXISBANK CL RIGD HDFCBANK TV18BRDCST SNOWMAN 500034 YESBANK UBNC ALLSEC 533261 532648 JPASSOCIAT 532800 FLEXITUFF 538635 AXBKY 532532 TTST 524075 PNJZY HDB PNB 500049 SNQVY
The Indian benchmark indices are trading on a flat to negative note this Tuesday morning with the Nifty50 trading at 11,433, down 5 points while the Sensex is trading lower by 5 points at 37,916.
JIPKY UBL BRTQY 532478 SYNDIBANK 532483 532480 500696 GODREJCP BRITANNIA SUNTV SBAZ AXB ALBK CLGQY ALBERTDA 532424 RAMANEWS CNRYY AXBA BAJAJFINSV 532276 533638 CANBK 507458 ANDHRABANK 500825 GODREJIND 532418 HINDUNILVR 532978 530239 532733 532215 SUVEN GDRJY 532461 AXISBANK CL 500356 SNOWMAN UBNC UBHOLDINGS JPASSOCIAT UNBWY FLEXITUFF 538635 AXBKY 532532 524075 PNJZY PNB SNQVY 500164
The escalating tariff war between the US and China had a ripple effect on Indian financial markets on Monday, roiling equity and forex markets alike.
AXB IDKQY HCTHY 532978 532215 AXBKY 535789 IBULHSGFIN AXBA BAJAJFINSV BAJFINANCE ZEEEY AXISBANK HCLTECH 505537 532281 BJJQY ZEEL 500034
The Indian benchmark indices have extended the earlier loses this Monday afternoon with the Nifty50 trading at 11,457, down 131 points while the Sensex is trading lower by 390 points at 38,999.
500325 511389 535789 JUSTDIAL USHAMART 532483 BJJQY RLNIY SBAZ GICHSGFIN BPCL AXB RELCAPITAL UHBTY YYBKY 511676 ALBERTDA JSWSTEEL CNRYY AXBA BAJAJFINSV BAJFINANCE BRQPY HINDPETRO 500104 LITL CANBK ABBOTINDIA 517146 500547 500228 RELIANCE IDBI 532978 532778 VIDEOIND 532215 535648 532461 AXISBANK RIGD 500034 500111 YESBANK UBNC 517354 HVLQY 500116 IDKQY 532648 AXBKY IBULHSGFIN 524075 PNJZY HAVELLS PNB 500488 JSTQY
The India benchmark indices continues to trade flat this Wednesday afternoon with the Nifty50 down 7 points at 11,731 while the Sensex is down 3 points at 38,893.
PWQFY 500325 532834 532514 511389 512599 532832 IGL TTKPRESTIG 532483 CAMLINFIN EICHERMOT CLNDY RLNIY SBAZ ANNRY AXB FSIC YYBKY 530005 JSWSTEEL CNRYY BRK.A AXBA BAJAJFINSV BATAINDIA TATASTEEL TATLY CANBK COALINDIA IBREALEST ADANIENT 500228 RELIANCE 532978 517506 VIDEOIND 532810 533278 532215 505200 500470 532187 532461 AXISBANK RIGD INDIACEM YESBANK UBNC ECQRY 517354 HVLQY INDUSINDBK 532648 AXBKY PFC TTST PNJZY HAVELLS PNB 500043
What a cracker of a Monday that was for the market! Bulls had it their way throughout the session, gaining with every passing hour. Benchmarks ended the day at record high levels. The Nifty managed to clock 11,700-mark as well.
500325 SUNDARMFIN 570002 RELIANCE FRL 532978 BHRQY SRTRANSFIN 511218 532454 BAJAJFINSV LICHSGFIN FRLDVR RIGD SRRQY 523574 LHFLY BHARTIARTL 590071 500253 RLNIY SNDMY
Take the time to let your siblings know how much you love them this Raksha Bandhan. What better way to show you care than by gifting your sister or brother a laptop, latest fashion apparel and accessories or a high-end smartphone? Besides, you need not worry about your salary being late or dipping into your savings. You can shop without exceeding your budget by shopping from the Bajaj Finserv EMI Network.
South Korean tech giant Samsung launched its latest and its most powerful flagship smartphone yet -- the Galaxy Note 9 -- in India on Wednesday, August 22. The much-anticipated device was unveiled globally earlier this month.
The market ended a truncated week on a good note, as benchmark indices closed with strong gains. The Nifty ended the day at a record closing high, while the Sensex ended higher by almost 300 points. Having said that, it failed to hold 38,000-mark.
PAGEIND 500449 UBL 532978 533155 TTNQY JUBLFOOD 532478 FILATEX RAIN BIRLAPREC 532540 JBLWY 509488 526227 522105 PGDQY EXIDEIND 517354 HVLQY GRAPHITE 532827 500339 UBHOLDINGS UNBWY HOCL EXQDY BAJAJFINSV BATAINDIA HAVELLS TCS 500086 507458 500043
The Indian benchmark indices this Thursday afternoon have again slipped and are trading in the red with the Nifty down 46 points at 11, 388 while the Sensex shed 149 points and is trading at 37,703.
GRASIM UBL DABUR 532712 511389 DBRQY 533137 532478 DEN SYNDIBANK 500096 RCOM BJJQY GAILF 500570 GRSJY AXB 532706 JSWSTEEL AXBA BAJAJFINSV 532276 BAJFINANCE BATAINDIA TATASTEEL TATLY GAILY KOTAKBANK 500300 507458 500188 HINDZINC ANDHRABANK 500228 532418 INOXLEISUR 532978 HNDZY 533155 VIDEOIND JUBLFOOD 532215 500470 AXISBANK JBLWY ZEEL TV18BRDCST TATAMOTORS 500034 UBNC 517354 HVLQY HINDALCO KMBKY UBHOLDINGS 532800 UNBWY AXBKY HNDNF GRSXY TTST ZEEEY 505537 HAVELLS 500247 500043 500440 TTM
The Indian benchmark indices this Thursday afternoon managed to regain some lost grounds are trading marginally in the red with the Nifty down 7 points at 11, 427 while the Sensex shed 25 points and is trading at 37,826.
GRASIM UBL DABUR 511389 532832 DBRQY 531500 533137 532478 DEN 535789 500096 532483 UCLQY BJJQY GAILF 500570 SBAZ RAJESHEXPO GRSJY AXB 532706 ULTRACEMCO JSWSTEEL CNRYY AXBA BAJAJFINSV BAJFINANCE GAILY KOTAKBANK 500300 CANBK 507458 IBREALEST 500188 HINDZINC 533150 500228 IDBI 533273 INOXLEISUR 532978 532538 HNDZY 533155 VIDEOIND JUBLFOOD 532215 532461 AXISBANK JBLWY ZEEL TATAMOTORS 500034 UBNC 517354 HVLQY HINDALCO 500116 KMBKY IBN IDKQY UBHOLDINGS UCLQF UNBWY AXBKY IBULHSGFIN HNDNF GRSXY ICICIBANK OBZIY GODREJPROP OBEROIRLTY PNJZY ZEEEY 532174 505537 HAVELLS PNB 500247 500440 TTM
The Indian benchmark indices this Thursday morning are trading in the red taking cues from its global peers with the Nifty down 30 points at 11, 404 while the Sensex shed 135 points and is trading at 37,716.
UBL PRMQY PATELENG 511389 532478 539437 500173 BJJQY GAILF 500570 EXIDEIND YYBKY JSWSTEEL EXQDY BAJAJFINSV BAJFINANCE TATASTEEL TATLY GAILY KOTAKBANK 500302 507458 500188 HINDZINC 524715 500228 532978 HNDZY VIDEOIND 500470 IDFCBANK TATAMOTORS 500034 YESBANK HINDALCO KMBKY IBN UBHOLDINGS 532648 UNBWY PEL HNDNF ICICIBANK TTST 531120 532174 GUJFLUORO SUNPHARMA 500247 500086 500440 TTM
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...